⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL244436 | 0.70 | — | — | |
| SCHEMBL9747606 | 0.70 | — | — | |
| SCHEMBL9745067 | 0.70 | — | — | |
| SCHEMBL9117829 | 0.70 | — | — | |
| SCHEMBL1374614 | 0.67 | — | — | |
| SCHEMBL9020848 | 0.65 | — | — | |
| SCHEMBL9642032 | 0.63 | — | — | |
| SCHEMBL9642039 | 0.63 | — | — | |
| SCHEMBL28820 | 0.59 | — | — | |
| SCHEMBL28819 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 855 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4373825-A1 | NITRILE SUMO INHIBITORS AND USES THEREOF | Suvalent Therapeutics, Inc. (US) | 2024-05-29 | — | — | EP | claimed |
| WO-2023137297-A2 | 5,6-DIHYDRO-4H-THIENO[2,3-C]PYRROLE SUMO INHIBITORS AND USES THEREOF | Suvalent Therapeutics, Inc. (US) | 2023-07-20 | — | — | WO | claimed |
| WO-2023004376-A1 | NITRILE SUMO INHIBITORS AND USES THEREOF | Suvalent Therapeutics, Inc. (US) | 2023-01-26 | — | — | WO | claimed |
| CN-110129033-B | Fluorescent probe for detecting butyrylcholine esterase activity and preparation method and application thereof | 浙江师范大学 | 2022-06-10 | — | — | CN | claimed |
| US-11149023-B2 | Substituted triazole derivatives and uses thereof | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2021-10-19 | — | — | US | claimed |
| EP-3700898-A1 | SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF | Bayer Pharma Aktiengesellschaft (DE) | 2020-09-02 | — | — | EP | claimed |
| US-20200255402-A1 | SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-08-13 | — | — | US | claimed |
| CN-111448161-A | Halogenated heteroalkenyl and heteroalkyl functionalized organic compounds and methods of making these compounds | 阿科玛股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| EP-3565905-A1 | STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES | MGI Tech Co., Ltd. (CN) | 2019-11-13 | — | — | EP | claimed |
| CN-110418847-A | By stepwise sequencing of unlabeled reversible terminators or natural nucleotides | COMPLETE GENOMICS INC | 2019-11-05 | — | — | CN | claimed |
| US-6025104-A | Toner and developer compositions with polyoxazoline resin particles | XEROX CORPORATION (US) | 2000-02-15 | — | — | US | claimed |
| EP-0136721-B1 | Carboxyalkenamidocephalosporins | SHIONOGI & CO (JP) | 1993-12-29 | — | — | EP | claimed |
| CN-1023322-C | Carboxyalkenamidocephalosporins | SHIONOGI & CO (JP) | 1993-12-29 | — | — | CN | claimed |
| EP-0433898-A2 | Analogs of oxetanyl purines and pyrimidines | ABBOTT LABORATORIES (US) | 1991-06-26 | — | — | EP | claimed |
| EP-0366059-A2 | Carbocyclic nucleoside analogs | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-05-02 | — | — | EP | claimed |
| EP-0334590-A2 | 3-(Substituted)-1-carba(dethia)-3-cephems and cephalosporins and a process for production therefor | ELI LILLY AND COMPANY (US) | 1989-09-27 | — | — | EP | claimed |
| US-4855418-A | Process for production of ceophalosporins | ELI LILLY AND COMPANY (US) | 1989-08-08 | — | — | US | claimed |
| US-4748170-A | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| US-4634697-A | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1987-01-06 | — | — | US | claimed |
| EP-0136721-A2 | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1985-04-10 | — | — | EP | claimed |